ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Galera Therapeutics Inc

Galera Therapeutics Inc (GRTX)

0.196
0.0007
(0.36%)
At close: May 17 4:00PM
0.196
0.0007
( 0.36% )
After Hours: 4:30PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.196
Bid
0.19
Ask
0.21
Volume
980,092
0.194 Day's Range 0.233
0.0853 52 Week Range 3.59
Market Cap
Previous Close
0.1953
Open
0.2048
Last Trade Time
16:22:21
Financial Volume
$ 206,092
VWAP
0.210278
Average Volume (3m)
2,136,971
Shares Outstanding
54,392,170
Dividend Yield
-
PE Ratio
-0.17
Earnings Per Share (EPS)
-1.09
Revenue
-
Net Profit
-59.08M

About Galera Therapeutics Inc

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Galera Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GRTX. The last closing price for Galera Therapeutics was $0.20. Over the last year, Galera Therapeutics shares have traded in a share price range of $ 0.0853 to $ 3.59.

Galera Therapeutics currently has 54,392,170 shares outstanding. The market capitalization of Galera Therapeutics is $10.33 million. Galera Therapeutics has a price to earnings ratio (PE ratio) of -0.17.

GRTX Latest News

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary...

Galera Adopts Limited Duration Stockholder Rights Agreement

MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.019210.85972850680.17680.2330.15316717420.18202108CS
40.00854.533333333330.18750.2330.15318010850.18638057CS
12-0.023-10.5022831050.2190.290.131421369710.20079772CS
260.051535.64013840830.14450.290.11518197060.19188088CS
52-3.184-94.2011834323.383.590.085326552130.43789718CS
156-7.544-97.46770025847.7410.790.085320852241.88994169CS
260-12.304-98.43212.519.50.085314238232.14834447CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SISIShineco Inc
$ 1.45
(51.04%)
2.74M
JYDJayud Global Logistics Ltd
$ 0.9605
(31.58%)
210.1k
IFBDInfobird Company Ltd
$ 4.15
(13.39%)
15.06k
AHGAkso Health Group
$ 0.79
(12.38%)
44.87k
VERBVerb Technology Company Inc
$ 0.1579
(10.03%)
781.97k
JAGXJaguar Health Inc
$ 0.13
(-49.71%)
12.47M
AKANAkanda Corporation
$ 0.1214
(-29.66%)
11.28M
VIRIVirios Therapeutics Inc
$ 0.25
(-28.86%)
224.1k
FLJFLJ Group Limited
$ 1.25
(-19.35%)
317.88k
JFBRJeffs Brands Ltd
$ 0.5399
(-16.68%)
500.48k
CRKNCrown Electrokinetics Corporation
$ 0.1675
(-2.05%)
39.16M
FFIEFaraday Future Intelligent Electric Inc
$ 1.13
(9.71%)
18.48M
JAGXJaguar Health Inc
$ 0.13
(-49.71%)
12.47M
AKANAkanda Corporation
$ 0.1214
(-29.66%)
11.28M
GWAVGreenwave Technology Solutions Inc
$ 0.156
(1.23%)
10.99M

GRTX Discussion

View Posts
glenn1919 glenn1919 4 weeks ago
GRTX..........................................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
glenn1919 glenn1919 1 month ago
GRTX..........................................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 1 month ago
Creeping up, letโ€™s do it again .
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 1 month ago
$GRTX
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 2 months ago
Over 11 million in volume with a high of .245 $
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 2 months ago
Sounds good
As of December 31, 2023, Galera had cash and cash equivalents of $18.3 million. Galera expects that its existing cash and cash equivalents will enable Galera to fund its operating expenses and capital expenditure requirements into the second quarter of 2025.
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 2 months ago
And some news will be great !
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 2 months ago
Need some volume !
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 2 months ago
Nice size bid !
๐Ÿ‘๏ธ0
FROZENFLAME FROZENFLAME 2 months ago
Interesting price, Iโ€™m in
$GTRX
๐Ÿ‘๏ธ0
Nealio Nealio 4 months ago
$GRTX - wants to move even higher...funds buying in? Anyone monitoring that? I need to find those links for Institutional reporting
๐Ÿ‘๏ธ0
glenn1919 glenn1919 4 months ago
GRTX............................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
crowin crowin 4 months ago
weeeee
๐Ÿ‘๏ธ0
Nealio Nealio 4 months ago
Looks like a lot of people gave up and sold too low...it may punch UP further tomorrow...certainly held gains ah's. News pending?
๐Ÿ‘๏ธ0
urge2surge urge2surge 5 months ago
13G 12% stake. Looks ready. Mc only 7 mill, cash and tangibles 28 mill. No cash needed until 2025. Buyout candidate IMO.
๐Ÿ‘๏ธ0
0210 0210 6 months ago
Close Watch: GRTX 8 x 34 + other daily technicals curling up. Now @0.14 - 0.15 > 0.1610 - 0.171(Parabolic SAR) >> 0.32, and then up to 0.50, +233% short-term target price.
๐Ÿ‘๏ธ0
0210 0210 6 months ago
GRTX @0.14 - 0.15 fwiw. "...risk/reward is still favorable. 28 mil cash on hand, and laying off over 70% of the workforce and stopping the 2 trials, should be ample enough money to carry them through all of 2024. Already have made it clear that they don't want to go through another trial for Avasopasem, as it is costly and time consuming, so if you are buying or going long here, you are simply playing[translation: ACCUMULATING, lol ] for one of the possible strategic maneuvers..."
Source: Click here.
๐Ÿ‘๏ธ0
0210 0210 6 months ago
TP: 0.25 min 0.50 max and/or 0.42 ave.(short-term TP = 3x or +200% from 0.14-.0.15 current pps) .

Source: 3 stock analysts. Click here.
๐Ÿ‘๏ธ0
glenn1919 glenn1919 6 months ago
GRTX...................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
knrorrel knrorrel 6 months ago
Why ? do you think it will go higher soon ?


๐Ÿ‘๏ธ0
Triple nickle Triple nickle 6 months ago
Never see these prices again
๐Ÿ‘๏ธ0
koolmc koolmc 6 months ago
lol you were telling peeps to dump few days ago
๐Ÿ‘๏ธ0
Tom turtles Tom turtles 6 months ago
Dumped at .145..TY stock God's...In .0919
๐Ÿ‘๏ธ0
chumfm chumfm 7 months ago
Seen this many times.This goose is cooked.Expect chapter 11 in the near future.Good luck and good trading.
๐Ÿ‘๏ธ0
Tom turtles Tom turtles 7 months ago
You may as well unload now...geez.. what a fiasco
๐Ÿ‘๏ธ0
Here Today Here Today 7 months ago
And in the case of IPIX like it is here with Galera, the FDA constantly wants more testing and more testing. But yet for an experimental MRNA shot which scientists and the medical community will not truly know the effects for another 5 years on oneโ€™s health, they green light. In my opinion, itโ€™s all about who greases whose palms!!!
๐Ÿ‘๏ธ0
Here Today Here Today 7 months ago
Overreaction??? This looks to be going down the route of IPIX. Both of these companies Galera and Innovation Pharma had a product for OM and both of them have been rejected by the FDA. Itโ€™s amazing to me the stupidity of how it goes especially since they have nothing that really works right now and patients that develop OM usually have to stop cancer treatments and then decide whether or not to continue once the symptoms subside and heal. And the cost for a severe OM patient to be treated is very, very expensive.
๐Ÿ‘๏ธ0
wickerman wickerman 7 months ago
$GRTX where's the guy who was pumping this trash all over iHub?
Next stop is BK and delisting.
๐Ÿ‘๏ธ0
ATM123 ATM123 7 months ago
Do the company has any IP property for buyout/merger with all the trails cancellations...
๐Ÿ‘๏ธ0
hondaboost hondaboost 7 months ago
Over reaction: GRTX, cash: $28.4 M. "Galera estimates that its balance of cash, cash equivalents and short-term investments as of September 30, 2023 was $28.4 million. or $0.7/share . "
๐Ÿ‘๏ธ0
Here Today Here Today 7 months ago
Not bad??? Check out market reaction. Down 50% pre market.
๐Ÿ‘๏ธ0
sc00pnDump sc00pnDump 7 months ago
News out, need to do another phase 3 tests and submit holding back other drug to save moneyโ€ฆ not bad
๐Ÿ‘๏ธ0
mistercellphoneman mistercellphoneman 7 months ago
website is back up
๐Ÿ‘๏ธ0
OmegaMoney29 OmegaMoney29 7 months ago
Wow
๐Ÿ‘๏ธ0
ATM123 ATM123 7 months ago
Website is down...Whats going on
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 7 months ago
Should be hearing something this week
๐Ÿ‘๏ธ0
OmegaMoney29 OmegaMoney29 7 months ago
I bet so
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 7 months ago
It is possible to fill that $2 gap Omega... Depends on how good the news is...
๐Ÿ‘๏ธ0
work-n-hard work-n-hard 7 months ago
...with Good Weather. lol
๐Ÿ‘๏ธ0
powerbattles powerbattles 7 months ago
Fully loaded at an average.185
๐Ÿ‘๏ธ0
OmegaMoney29 OmegaMoney29 7 months ago
Early Christmas 🎄
๐Ÿ‘๏ธ0
work-n-hard work-n-hard 7 months ago
Gap fill would be excellent.
๐Ÿ‘๏ธ0
OmegaMoney29 OmegaMoney29 7 months ago
fda news run to $2 tomorrow??
๐Ÿ‘๏ธ0
work-n-hard work-n-hard 7 months ago
Yep, I think that it's leaking out that news is coming. Maybe this afternoon or tomorrow???
๐Ÿ‘๏ธ0
Golden Cross Golden Cross 7 months ago
Think we have seen the bottom...Looking better here
๐Ÿ‘๏ธ0
work-n-hard work-n-hard 7 months ago
https://www.nasdaq.com/press-release/galera-schedules-type-a-meeting-with-fda-to-discuss-next-steps-for-avasopasem-2023-09
๐Ÿ‘๏ธ0
bluebird50 bluebird50 7 months ago
Whatโ€™s the intended date?
๐Ÿ‘๏ธ0
powerbattles powerbattles 7 months ago
$GRTX According to the FDA guidance document titled โ€œFormal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Guidance for Industryโ€, after a Type A meeting, the FDA will provide written feedback to the sponsor or applicant within 14 calendar days of the meeting. This feedback will include a summary of the meeting, any agreements reached during the meeting, and any action items that need to be addressed by either party.

Agreements that could be reached during a Type A meeting include:

Agreement on clinical trial design: The FDA may agree to a sponsorโ€™s or applicantโ€™s proposed clinical trial design.

Agreement on endpoints: The FDA may agree to a sponsorโ€™s or applicantโ€™s proposed endpoints for a clinical trial.

Agreement on statistical analysis: The FDA may agree to a sponsorโ€™s or applicantโ€™s proposed statistical analysis plan for a clinical trial.

Agreement on labeling: The FDA may agree to a sponsorโ€™s or applicantโ€™s proposed labeling for a drug product.
๐Ÿ‘๏ธ0
work-n-hard work-n-hard 7 months ago
? I sent it the day before.
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 7 months ago
Give it 10 minutes
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock